KETAMINE-based drug 'cuts risk of postnatal depression'

Giving mothers a ketamine-based drug immediately after childbirth reduces their risk of postnatal , a trial has found.

A single low dose of esketamine, a high-strength form of powerful hallucinogenic, decreased the number of major depressive episodes 42 days after birth by about three-quarters.

The study suggests the medication, used as an anaesthetic and antidepressant, should be considered for new mothers who show symptoms of depression during pregnancy.

Load More